Inventor

STREIN KLAUS

DE35 patents

⚠️ This page may combine multiple inventors who share the name “STREIN KLAUS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

STREIN KLAUS

BOEHRINGER MANNHEIM GMBH

Regimen for treatment or prophylaxis of osteoporosis

Beta-blocking oxindole derivatives

Tricyclic benzimidazole compounds, pharmaceutical compositions and methods of use

Benzodipyrroles, processes for the preparation thereof and pharmaceutical compositions containing them

Pyrrolobenzimidazoles and pharmaceutical compositions containing them

Parathormone fragments, their preparation and medicaments containing these

Indoline compounds for synthesis of pharmaceutically active pyrrolobenzimidazoles

Tricyclic benzimidazole compounds, pharmaceutical compositions and methods of use

Ureidoindoles, pharmaceutical compositions and methods for erythrocyte and thrombocyte aggregation inhibition

Pyrrolobenzimidazoles for treating heart or circulatory diseases

Pharmaceutical phenylacetonitrile derivatives

Pharmaceutical lactam compositions for inhibition of erythrocyte and thrombocyte aggregation

Aminopropanol derivatives, processes for the preparation thereof, the use thereof and pharmaceutical compositions containing them

Pyrrolobenzimidazoles, pharmaceutical compositions containing them, and use of them to treat certain heart and circulatory diseases

Pyrrolobenzimidazoles, pharmaceutical compositions containing them, and use of them to treat certain heart and circulatory diseases

Pyrrolobenzimidazoles, pharmaceutical compositions containing them and method of using them to treat certain heart and circulatory diseases

α-(aminoalkylaminomethyl)phenylmethanols, composition containing them, and use thereof to treat certain heart and circulatory diseases

Indazoloxypropanolamine derivatives and use in combating, and for the prophylaxis of, cardiac and circulatory diseases

Cardiotonic benzimidazoles

Certain pyridinoylamino-indolin-2-one derivatives

Use of alkylenediamine derivatives for the treatment of blood flow disturbances and pharmaceutical compositions containing them

Use of alkylenediamine derivatives for the treatment of blood flow disturbances and pharmaceutical compositions containing them

ENGMAB AG

Method for the selection of antibodies against BCMA

Bispecific antibodies against CD3 and BCMA

Bispecific antibodies against CD3ϵ and BCMA

ENGMAB SARL

Monoclonal antibodies against BCMA

Method for the selection of antibodies against BCMA

Bispecific antibody against BCMA and CD3 and an immunological drug for combined use in treating multiple myeloma

BOEHRINGER MANNHEIM PHARM CORP

Method of treatment for decreasing mortality resulting from congestive heart failure

Use of carbazole compounds for the treatment of congestive heart failure

SB PHARMCO INC

Method of treatment for decreasing mortality resulting from congestive heart failure

Use of carbazole compounds for the treatment of congestive heart failure

BRISTOL MYERS SQUIBB CO

Bispecific antibodies against CD3EPSILON and ROR1

Lamkap Bio Alpha AG

Bispecific antibodies against CEACAM5 and CD3

LAMKAP BIO BETA LTD

Bispecific antibodies against CEACAM5 and CD47